secretary@fonse.eu

Project – Biosimilars Nurses Guide version 2.0

Background

In 2018 the ESNO Biosimilars focus group contributed to the shaping of the Biosimilars Information and Communication guide for nurses. That was a project that spanned a year with support from Medicines for Europe and EFPIA. That project was a result of the publication of the Information guide on Biosimilars for health professionals of the EMA. The ESNO contributed to this, but was ultimately very medical oriented. With Medicines for Europe and EFPIA we then created a guide in line with the guide for patients. The guide has been published in 8 languages, printed in English and Dutch. The intention was to further shape it afterwards, such as making a sequel based on new information and insights. Also conducting online educational activities and presentations. The latter is still in the planning, but depends on the right moment and people and institutions who want to support it


Reasons for updating

  • Have a close detaille update on the content and suggest recomendations
  • Include European national examples and experiances
  • Include examples per therapeutic areas
    • Rheumatology
    • Cancer
    • Diabetes
    • Dermatology
    • Oncology
    • Inflammatory Bowel Diseases
    • Oftalmologie (new)
  • Benefit programs examples
  • Establish committee to contribute to events and publications

Planning draft Second Version

For 2021
– April: connect again with members and expand with new specialist nurses
– 31 May 19:00 (CEST): follow up meeting Biosimilar focus group registrate under this link
– September: collection of new insights
– October: general meeting with all stakeholders
– December: scheduling revision of Guide
For 2022
January:….
April: launch during event in Amsterdam


ESNO focus group on Biosimilars

Start proces issue on the ‘Principles of Specialist Nursing on Biosimilars’ in the Springer Nature series. Schedule: start mid 2021 – publication end 2022


ESNO focus group on Biosimilars

  1. Hanneke Voorneveld: Rheumatology Nurses (Netherlands)
  2. Patrick Crombez: Oncology Nurses (Belgium)
  3. Corinne Scicluna: Dermatology Nurses (Malta)
  4. Wioletta Mędrzycka-Dąbrowska – anesthesia and intensive care nursing – Medical University of Gdańsk Poland
  5. Sabina Krupa – anesthesia and intensive care nursing – Medical University of Rzeszów Poland
  6. Susan Elvidge – Editor (UK)
  7. Ber Oomen, (Netherlands)
  8. Adriano Friganovic – anesthesia and intensive care nursing – (Croatia)
  9. Alexandra Isabel Gomes Pereira, Oncology, (Portugal)
  10. Paul Corners, medical expert (UK)
  11. Marijke Quaghebeur – Oncology – UZ Gent – Belgium
  12. Johan de Munter – Oncology – UZ Gent – Belgium
  13. Eveline Hoefkens – IBD – Belgium
  14. Susana Reis – Portugal

Literature – Biosimilars and Nursing

Friganovic and Waller
Biosimilars in oncology key role of nurses

Liese Barbier
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice


Contact and collaborative partners

Project lead: Ber Oomen
projects@fonse.eu

Sponsors: ….


Relevant events to participate